A recent study reveals that patients who stop using popular weight-loss injections like Mounjaro or Wegovy tend to recover shed pounds much more quickly than those who stop traditional lifestyle plans.
Findings released in a major health publication points out that while overweight individuals can lose about a fifth of their body weight while on the medication, the weight is regained at an average rate of 0.8 kg per month once they quit.
"Users purchasing such medications need to be cognizant of the potential of quick rebound weight gain when the medication is stopped," warns researcher Dr. Susan Jebb.
That rate of recovery suggests a reversion to original weight in about one and a half years.
Comparing Therapies
The study, which looked at dozens of trials involving over 9,000 of participants, contrasted the outcomes of GLP-1 agonists with other pills.
Researchers emphasize that people who shed pounds through lifestyle changes alone generally experience a less rapid weight regain—perhaps 0.1 kg a month—post-intervention.
Understanding the Quick Regain
Doctors suggest the way of the jabs explains the heightened rebound.
These medications copy a natural hormone called GLP-1, which moderates appetite.
"Artificially providing GLP-1 concentrations several times higher than the body's typical production may cause the system to generate a reduced amount of its own natural GLP-1, and could reduce sensitivity to its actions," said Dr. Adam Collins, a nutrition specialist.
"Stopping of this GLP-1 'fix' leads to hunger is unsuppressed, making overeating a significant risk."
A Chronic Issue?
Health authorities recommend the injections for people with obesity-related health risks, accompanied by recommended lifestyle changes.
Many experts contend that, given the likelihood of weight regain, the treatment should be considered ongoing.
This view is reinforced by drug manufacturers, who say that the findings "highlight the persistent character of obesity," akin to managing conditions like high blood pressure.
Patient Experiences
Users who have discontinued the medication explain a powerful resurgence of appetite.
"I experienced a trigger activating and you become ravenous," described one woman.
The struggle is compounded if users have not established permanent lifestyle or habit changes during therapy.
Widespread Interest
Survey data suggest that millions of adults in the UK have tried these injections in the last 12 months, with demand being substantial.
- Adoption is higher among females compared to males.
- The middle-aged demographic shows the highest usage rates.
- Many obtain the drugs through private prescriptions rather than the NHS.
In conclusion, experts emphasize that while these medications are potent tools for weight loss, they are not a magic fix and lasting health benefits likely depends on ongoing behavioural support.
